Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

NCT07420296 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

198

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica Spectrum Disorders (NMOSD)

Interventions

BIOLOGICAL: Eculizumab administration
DRUG: High-dose corticosteroid pulse therapy
PROCEDURE: Plasma exchange (PE)

Sponsor

Tianjin Medical University General Hospital